Although magnetic resonance imaging is a standard investigation in neurodegenerative disease, sensitive and specific markers for the underlying histopathological diagnosis are largely lacking. This report presents evidence to indicate that corticobasal degeneration and progressive supranuclear palsy, in particular, might be identifiable at a single subject level with diffusion tensor imaging. Patients with clinical diagnoses of Alzheimer's disease, semantic dementia and non-fluent primary progressive aphasia (n = 9 each) were contrasted with control subjects (n = 26) with the diffusion tensor imaging measures: fractional anisotropy, axial and radial diffusivity. At 1 year follow-up, all participants with non-fluent primary progressive aphasia had evolved either corticobasal degeneration (n = 5) or progressive supranuclear palsy (n = 4). The corticobasal degeneration/progressive supranuclear palsy set showed white matter abnormalities involving the entire cerebrum. Individual maps were similar to the group level results, even in the most minimally impaired patients. Fractional anisotropy was consistently the most sensitive metric. In Alzheimer's disease and semantic dementia, by contrast, group level and individual analyses revealed limited areas of abnormality centred on the posterior cingulate and rostral temporal lobes, respectively. In both groups radial diffusivity was the most sensitive metric. Scrutiny of the standard scores for each group's most sensitive metric revealed that, although the values for every patient with corticobasal degeneration or progressive supranuclear palsy fell outside 95% of the normal mean, none of the other two groups' members had values outside this range. Further underscoring the hypothesis that this finding relates specifically to a diffuse pathological process in the white matter of the tauopathies, and is not merely a function of disease severity, a grey matter analysis consisting of group level voxel-based morphometry revealed only focal areas of atrophy in all three groups. Consistent with past reports for the respective clinical syndromes, these were centred on the left frontal operculum and caudate nucleus in non-fluent primary progressive aphasia (the corticobasal degeneration/progressive supranuclear palsy set), anterior temporal lobes in semantic dementia, and hippocampus and posterior cingulate gyrus in Alzheimer's disease. Detection of this extensive white matter lesion in corticobasal degeneration and progressive supranuclear palsy-a pathologically proven feature of these conditions-in single subjects with diffusion tensor imaging appears to have strong diagnostic marker potential for these diseases.
Introduction
The pathological underpinning of a clinical dementia syndrome is a probabilistic diagnosis in life. In some circumstances, for instance where all indicators point to a typical clinical presentation of Alzheimer's disease, the likelihood of Alzheimer's pathology is exceedingly high (Alladi et al., 2007) . Some clinical dementia syndromes are, however, far more heterogeneous in terms of their pathological substrate, and for these more specific in vivo imaging markers of pathology are desirable. Primary progressive aphasia is arguably the most difficult of these as it can be associated with ubiquitin-staining pathology [usually TAR DNA-binding protein 43 (TDP-43)-positive], tauopathies (such as corticobasal degeneration or progressive supranuclear palsy) or Alzheimer's pathology (Gorno-Tempini et al., 2011) .
The advent of amyloid ligand imaging with PET has enabled in vivo visualization of Alzheimer's pathology. On the other hand, the high prevalence of incidental Alzheimer's pathology in later life, plus emerging evidence that this scan modality becomes positive for amyloid years before onset of symptoms, mean that its most definitive clinical role would be in ruling out Alzheimer's disease-i.e. a 'positive' amyloid scan does not prove a causal role for Alzheimer's pathology in a clinical dementia syndrome (Caso et al., 2012) . Differentiating between different types of dementia-causing non-Alzheimer's pathologies with imaging is even more difficult as there are at present no specific ligands for inclusions such as tau, TDP-43 or alpha synuclein etc.
A further challenge to developing predictors of non-Alzheimer's pathologies is identification of robust markers for single subject diagnosis. Although a vast number of imaging studies have been published on the atrophy or metabolic profiles of clinical dementia syndromes, very few have examined discriminability of differing pathologies in clinically ambiguous presentations. Furthermore, studies taking this further important step have almost all reported group-level findings without single subject validation. This report presents the first evidence to indicate that the tauopathies-corticobasal degeneration and progressive supranuclear palsy-might be identifiable at a single-subject level with diffusion tensor imaging.
Materials and methods

Participants
The study cohort comprised four groups: nine participants with an initial clinical diagnosis of non-fluent primary progressive aphasia who at 12-months follow-up had evolved a pattern of either corticobasal degeneration (five patients) or progressive supranuclear palsy (four patients, one of whom has since died and was confirmed at necropsy to have progressive supranuclear palsy pathology); nine patients with a clinical presentation of typical Alzheimer's disease; nine patients with a diagnosis of semantic dementia; and 26 healthy, ageand education-matched control participants. All patients were recruited from the memory clinics held at Addenbrooke's Hospital, University of Cambridge, UK. Written informed consent was obtained from the participants and, where appropriate, their next of kin. The study was approved by the regional Ethics Committee.
The diagnoses of neurodegenerative syndromes were made in accordance with accepted criteria for diagnosis of Alzheimer's disease (Dubois et al., 2007) , semantic dementia (Hodges and Patterson, 2007) , non-fluent primary progressive aphasia (Neary et al., 1998; Mesulam, 2001) , corticobasal degeneration (Litvan et al., 1997) and progressive supranuclear palsy (Litvan et al., 1996) . Due to the presumed similar underlying pathology in corticobasal degeneration and progressive supranuclear palsy (Boeve et al., 2003; Scaravilli et al., 2005) , scans for these two subgroups were combined to form a corticobasal degeneration/progressive supranuclear palsy set for the group level analyses. Prospective participants were excluded if there was evidence of significant leukoaraiosis in their T 2 -weighted imaging (excluded three patients). All control participants were free of cognitive and psychiatric illnesses as evidenced by their performance in clinical and neuropsychological evaluations.
Neuropsychological battery
All patients underwent a detailed neuropsychological assessment prior to imaging. The tests included global measures: Mini-Mental State Examination (Folstein et al., 1975) and the revised version of Addenbrooke's Cognitive Examination (ACE-R) (Mioshi et al., 2006) ; forward and backward digit span subtests of the Wechsler Memory Scale (Wechsler, 1997) ; letter and category fluency subtests of the ACE-R; the Camel and Cactus Test of non-verbal semantic abilities (Bozeat et al., 2000) ; the 64-item naming subtest of the Cambridge semantic memory battery (Hodges and Patterson, 2007) ; cube analysis from the Visual and Object Space Perception battery (VOSP) (Warrington and James, 1991) ; Delis-Kaplan Executive Function System (D-KEFS) Trail making test (Delis et al., 2001) ; and copy and delayed recall of the Rey-Osterrieth complex figure. We also designed a novel apraxia assessment battery for assessment of orobuccal and limb apraxia for both transitive and intransitive gestures.
Predictive Analytics SoftWare version 18 was used for analysis of the neuropsychological data. For the parametric subset of the markers, one-way ANOVA was used to compare the performance in different groups and Gabriel's test was used for post hoc comparisons. For variables with a skewed distribution, the Kruskal-Wallis test was used for multiple group comparisons and the Mann Whitney U test with Bonferroni correction to explore the underlying group differences when the Kruskal-Wallis test result was significant. In all neuropsychological tests, a two tailed P-value 5 0.05 was considered significant.
Imaging
Study participants were scanned within an average of 1.1 months [standard deviation (SD) 0.6 months] from cognitive assessment. In the corticobasal degeneration/progressive supranuclear palsy set, the scans were obtained while the patients still had a clinical diagnosis of non-fluent primary progressive aphasia with no definite clinical evidence of conversion to either corticobasal degeneration or progressive supranuclear palsy. All MRI scans were performed on a Siemens Trio 3 T system (Siemens Medical Systems).
Diffusion tensor imaging
Whole-brain diffusion experiments were sensitized along 63 non-colinear directions and one b-value of 1000 s/mm 2 . Full details of the data acquisition protocol have been published previously (AcostaCabronero et al., 2011) . Diffusion tensor imaging maps for axial and radial diffusivity and fractional anisotropy were generated, skeletonized and tested using standard tract-based spatial statistics (TBSS v1.2) (Smith et al., 2006) as described elsewhere (Acosta-Cabronero et al., 2011). For group-level comparisons, patient-cohort diffusion tensor imaging maps were contrasted against those from control participants and the resulting statistical maps were thresholded at the stringent P-value of 0.01, corrected for multiple comparisons. Tractbased spatial statistics was also utilized to detect white matter abnormalities in individual subjects by testing diffusion tensor imaging data from single patients against the control group. The permutation-based method of tract-based spatial statistics enables the identification of clusters in which diffusivity (or anisotropy) from a single subject ranks worse than all control participants. The stringency of the statistical threshold is therefore dictated by the size of the control group. In other words, the most stringent P-value would be equal to one divided by the total number of possible permutations, which in turn is defined by the number of control participants. Controls (n = 26) allowed for thresholding the statistical maps at P 5 0.04, uncorrected for multiple comparisons.
For each metric, we also calculated the proportion of abnormal voxels at the centre of white matter tracts. Group-level results represent the number of abnormal voxels-inferred from the corrected statistical maps thresholded at 0.01-divided by the total number of voxels included in the analysis. For individual patients, the threshold used to infer the extent of abnormality was 0.04 uncorrected. Note that in order to avoid the arbitrary limitations imposed by statistical tests, we also computed standard scores for each diffusion tensor imaging metric at individual and group levels.
Volumetric T 1 imaging ) before group level analysis. We used two sample t-test implemented in statistical parametric mapping version 5 (Ashburner and Friston, 2005) for voxel-based morphometry of the patient groups' grey matter volumes against controls. The statistical maps were thresholded at a stringent level of P 5 0.01, corrected for multiple comparisons (false discovery rate = 0.01). In all calculations, age and total intracranial volumes [derived from the sum of grey matter, white matter and CSF were fed into the statistical models as nuisance covariates.
Results
Demographics and neuropsychology Table 1 summarizes the demographic and neuropsychological data for each participating group. There was no statistical difference between the groups for any of the demographic parameters. The three patient groups showed comparable performances in the general neuropsychological tests (Mini-Mental State Examination and ACE-R) that were significantly worse than controls. At a group level, while patients with Alzheimer's disease were impaired at non-verbal memory and visuospatial tasks, patients with semantic dementia were particularly poor at naming and the test of non-verbal semantic knowledge (Camel and Cactus Test). The corticobasal degeneration/progressive supranuclear palsy group, on the other hand, had relatively preserved semantic knowledge but was impaired at tests of executive function and visuospatial tasks. Also it was the only group with a significant impairment in the assessments of orobuccal and limb praxis.
Imaging analysis
Corticobasal degeneration/progressive supranuclear palsy
As previously mentioned, the study cohort included four and five cases, respectively, whose later clinical profiles indicated progressive supranuclear palsy and corticobasal degeneration; diffusion tensor imaging maps for these subgroups were combined for group level comparisons. The corticobasal degeneration/progressive supranuclear palsy group (n = 9) showed extensive fractional anisotropy and radial diffusivity white matter abnormalities essentially involving the entire cerebrum but with more intense predilection for anterior regions (Fig. 1) . Fractional anisotropy appeared to be the most sensitive metric (Table 2) in detecting group level abnormalities, closely followed by radial diffusivity; axial diffusivity revealed relatively restricted, mainly anterior, areas of tract degeneration.
At an individual level, the patterns of abnormality looked remarkably similar to the group level results with no obvious differences between those with a corticobasal degeneration versus those with a progressive supranuclear palsy phenotype ( Fig. 2 and Supplementary Fig. 1 ). Despite some variation in the distribution and extent of degeneration, all scans revealed a qualitatively distinct pattern of widespread involvement of white matter tracts with an anterior bias. Fractional anisotropy was consistently the most sensitive metric although, again, it was followed closely by radial diffusivity. Compared to the other groups, abnormalities accounted for a significant proportion of white matter (Table 2) . Moreover, the standard scores for both radial diffusivity and fractional anisotropy were outside the 95% confidence interval of normal mean in all individuals and at a group level (Table 2) .
Group level comparison of grey matter density using voxelbased morphometry revealed a small cluster of cortical atrophy centred on the left frontal operculum with a less significant involvement of the left sided premotor area and caudate nucleus (Fig. 1 ).
Alzheimer's disease
Group level comparisons revealed limited areas of reduced fractional anisotropy and increased axial diffusivity and radial diffusivity in a number of posterior association and projection tracts (Fig. 1) . As demonstrated in Table 2 , radial diffusivity was the most sensitive metric in detecting group level abnormalities followed by axial diffusivity and fractional anisotropy. For none of the metrics, however, did the proportion of abnormal voxels exceed 5% of the white matter skeleton. Individual scans showed less confluent abnormalities in a similar distribution ( Fig. 2 and Supplementary Fig. 1 ). Consistent with the group level findings, different diffusion tensor imaging metrics showed differential sensitivity, with radial diffusivity the most consistent in detecting abnormalities at an individual level. It is worth (64) 57 ( The numbers in the parentheses represent the maximum scores for the tests; symptom duration was based on caregiver accounts of when the patients' cognitive decline first began to emerge. *P 5 0.05 compared to controls; **P 5 0.01 compared to controls; ***P 5 0.001 compared to controls; # P 5 0.01 compared to corticobasal degeneration; ## P 5 0.001 emphasizing, however, that for the majority of the patients, the proportion of abnormal tracts remained 55%. Moreover, scrutiny of standard scores in different diffusion tensor imaging metrics, both at a group level and individually, revealed values within the normal range (Table 2) . Voxel-based morphometry of the group revealed bilateral atrophy of the hippocampi and posterior cingulate gyri with some minor patchy changes in postero-lateral temporo-parietal areas (Fig. 1) .
Semantic dementia
For the semantic dementia group, areas of reduced fractional anisotropy and increased axial and radial diffusivities were mainly centred on the anterior temporal and, less significantly, orbito-frontal areas (Fig. 1) . Fractional anisotropy and radial diffusivity maps revealed larger areas of abnormality when compared with axial diffusivity (Table 2) . Similarly, individual diffusion tensor imaging comparisons revealed a consistent asymmetrical (mainly left sided) involvement of anterior temporal tracts ( Fig. 2 and Supplementary Fig. 1 ). Amongst the different metrics, radial diffusivity was uniformly the most sensitive in all patients with semantic dementia (Table 2) . This group's voxel-based morphometry analysis identified severe grey matter atrophy in both anterior temporal lobes that was more significant on the left where it extended to posterior temporal areas. There was also some minor ventral frontal involvement (Fig. 1) .
Discussion
The results demonstrate that a qualitatively distinct pattern of diffusion tensor behaviour can be identified at a single subject level for the presumed tauopathies, corticobasal degeneration/progressive supranuclear palsy. Single subject analysis in Alzheimer's disease yielded fairly minimal changes in radial and axial diffusion that, consistent with previous group level analysis (Acosta-Cabronero et al., 2010; Bosch et al., 2012) , was most apparent in the white matter of the posterior cingulate and adjacent posterior parieto-temporal regions. In semantic dementia, Note the qualitatively distinct pattern of widespread involvement of white matter tracts in the corticobasal degeneration/progressive supranuclear palsy group. ACE-R = Addenbrooke's cognitive examination-revised; CBD = corticobasal degeneration; FA = fractional anisotropy; 1 = axial diffusivity; PSP = progressive supranuclear palsy; RD = radial diffusivity.
changes were focused on the rostral temporal lobe and principally involved an increase in radial diffusion, again consistent with previous group level results (Acosta-Cabronero et al., 2011).
The most striking finding, though, was that individuals with non-fluent primary progressive aphasia had profound and diffuse changes throughout essentially all of the white matter. This predominantly involved increased radial diffusion and therefore Figure 2 Single-subject (P 5 0.04 uncorrected) demonstration of white matter abnormalities for diffusivity and anisotropy metrics. AD = Alzheimer disease; CBD = corticobasal degeneration; PSP = progressive supranuclear palsy; SD = semantic dementia. decreased fractional anisotropy. Because, at follow-up, these individuals had developed signs of either corticobasal degeneration or progressive supranuclear palsy, it is proposed that this diffuse white matter lesion is a diagnostic marker for this class of tauopathies. Although this has been shown in only nine such patients in the present study, it is important to stress that the findings were seen in each and every patient in the group, and in none of the 18 patients without putative corticobasal degeneration/progressive supranuclear palsy; furthermore, there was no overlap at all between the corticobasal degeneration/progressive supranuclear palsy group and the other two patient groups in terms of the diffusion tensor imaging finding. The probability of these results occurring in this way by chance (i.e. all nine of the patients with corticobasal degeneration/progressive supranuclear palsy, and none of the other patients, having this diffusion tensor imaging profile) is of the order of one in 10 million. In agreement with the findings of the present study, previous group level comparisons investigating the patterns of white matter degeneration in progressive supranuclear palsy and corticobasal degeneration have indicated extensive white matter abnormalities in these two conditions (Erbetta et al., 2009; Knake et al., 2010; Saini et al., 2011) .
With the exception of one pathologically verified patient, the diagnosis of corticobasal degeneration/progressive supranuclear palsy in this study was clinical and further pathological verification will be necessary to confirm the specificity of these findings in future work, particularly as features of a corticobasal syndrome can also be associated with Alzheimer's pathology (Chand et al., 2006) . That said, previous clinicopathological studies have found that progressive non-fluent aphasia occurring before or after the motor features of corticobasal degeneration or progressive supranuclear palsy in the same patient is highly predictive for these pathological entities (Kertesz et al., 2005; Shelley et al., 2009) . The specificity of the findings is also reinforced by the observation that the diffuse white matter lesion of the patients with corticobasal degeneration or progressive supranuclear palsy was not seen in any patients with semantic dementia. Previous clinicopathological studies indicate that ubiquitin-positive TDP-43 is the typical pathology in semantic dementia whereas tauopathies are relatively rare (Rohrer et al., 2011) . The individuals with semantic dementia also showed a specific profile, with changes most significant in the rostral temporal lobe (spilling over into the ventral frontal region in some cases) that were predominantly driven by increased radial diffusion. This pattern, while specific at a single-subject level, is not as groundbreaking as the corticobasal degeneration/progressive supranuclear palsy finding because atrophy in the rostral temporal lobe on standard structural imaging also has predictive value for pathology in semantic dementia ). This could alter, however, if the diffusion tensor imaging pattern in the rare case of semantic dementia associated with tau pathology had a qualitatively different diffusion tensor imaging profile to those with TDP-43, because previous structural imaging work reported such cases to be identical in terms of atrophy alone .
Returning to the key finding of this study, a crucial question is why patients with corticobasal degeneration or progressive supranuclear palsy have such diffuse changes in white matter. The answer seems unlikely to relate to grey matter atrophy or axonal loss. If it did, in comparison to the other groups, one would expect these patients to have a severe and global dementia with wide spread cortical atrophy, but this was clearly not the case. At a group level, patients with corticobasal degeneration or progressive supranuclear palsy were equivalent to the other two patient groups on the global measures of Mini-Mental State Examination and ACE-R and showed a rather restricted pattern of cortical atrophy that was in agreement with the previous group studies of non-fluent primary progressive aphasia (Whitwell et al., 2004; Josephs et al., 2006; Wilson et al., 2010) . Moreover, as demonstrated in Table 2 , there was no distinctive difference in the extent of white matter abnormality between those individuals with progressive supranuclear palsy or corticobasal degeneration with a very mild degree of cognitive impairment-as evidenced by their global cognitive scores-and those who had very low scores in ACE-R. Therefore, we speculate that this diffuse white matter change relates to the known glial pathology in these diseases (Forman et al., 2002) , which, nonetheless, could interfere with action potential propagation. The diffuse distribution of the diffusion tensor imaging changes could, therefore, offer a credible explanation for the profound slowing of cognitive processing that is a hallmark of corticobasal degeneration or progressive supranuclear palsy (Dubois et al., 1988) .
A likely related finding is that previous studies have identified profound levels of insoluble tau in the white matter of patients with progressive supranuclear palsy (Zhukareva et al., 2006) and corticobasal degeneration (Forman et al., 2002) . In the present study there was no discernable difference in the diffusion tensor imaging pattern of those who evolved progressive supranuclear palsy versus corticobasal degeneration. This finding has some resonance with the known close relationship between these two pathologies (Boeve et al., 2003; Scaravilli et al., 2005) ; for instance, both are associated with the same predominantly fourrepeat tau isoform. Interestingly, Pick's disease, in which there is predominantly three-repeat tau (Cairns et al., 2007) , has also been shown to exhibit prominent white matter tau pathology . It will therefore be interesting for future studies to examine whether Pick's disease, and indeed other tauopathies, yield similar or different diffusion changes to corticobasal degeneration/progressive supranuclear palsy. The present results offer strong evidence. however, that the corticobasal degeneration/progressive supranuclear palsy result is not a nonspecific feature of any tauopathy because the results in Alzheimer's disease, the most common tau disorder, were completely dissimilar. This finding accords with the known cortical predilection, and relative sparing of subcortical areas, for tau pathology in Alzheimer's disease (Zhukareva et al., 2006) that stands in sharp contrast to the subcortical, mainly glial, pathology seen in corticobasal degeneration/progressive supranuclear palsy. One final point to emphasize on the underlying mechanism of the diffusion tensor imaging lesion is that we do not believe that this relates to tau pathology per se, but rather to its relationship to surrounding tissue and its resulting impact on diffusivity of water in these specific diseases.
The findings of the present study indicate a clear potential for utilization of diffusion tensor imaging data as a state-specific diagnostic biomarker for corticobasal degeneration/progressive supranuclear palsy. The clinical importance of this finding becomes more apparent when one considers that none of the available imaging, serological or CSF biomarkers are capable of making a positive prediction for these conditions (Toledo et al., 2012) . Although one could argue that the average duration of symptoms in the corticobasal degeneration/progressive supranuclear palsy group was 3 years, delayed presentation due to the insidious onset of the symptoms is a well-recognized feature of all neurodegenerative diseases. The fact that six of nine patients with nonfluent primary progressive aphasia were recruited following their first presentation to the clinic further corroborates this claim. Moreover, the corticobasal degeneration/progressive supranuclear palsy group had the shortest symptom duration amongst the groups and this argues against widespread white matter abnormalities being a mere consequence of advanced disease.
There are some important caveats to note with respect to future studies. First is that the approach employed here requires a relatively large control database for comparison. The second is that diffusion tensor imaging acquisition can be realized in a multitude of different forms with respect to strength of magnetic field, resolution, directions and b-values, and these technical details may prove to be critically important. The current results were acquired at 3 T with 63 non-colinear directions; it cannot be assumed without empirical validation that less detailed acquisitions or lower field strengths would yield similar results. Moreover, it is worth emphasizing that we excluded those participants whose structural MRI revealed a significant degree of white matter disease (leukoariosis). It will be of interest to assess-in future studies-whether corticobasal degeneration/progressive supranuclear palsy can be differentiated from other diseases in cases with concomitant leukoariosis or whether the findings are only valid once leukoariosis is excluded. A final point that must be stressed is that the present study explicitly selected cases with non-fluent primary progressive aphasia that developed clinical corticobasal degeneration or progressive supranuclear palsy because this combination is known to be highly predictive of corticobasal degeneration/progressive supranuclear palsy pathology. The study, therefore, is not directly comparable to diffusion tensor imaging studies of nonfluent primary progressive aphasia as a clinical syndrome (Schwindt et al., 2011) . In the latter, one might expect heterogeneous pathology (tau, TDP-43 and even Alzheimer's pathology) and therefore less extensive white matter changes depending on the proportion of tau cases that were included. A corollary of this issue is that the current results raise serious concerns about using diffusion tensor imaging to map white matter tract degeneration in non-fluent primary progressive aphasia; if a cohort contains a large proportion of tau cases, changes might be seen that do not relate to axonal loss. As discussed above, the hypothesis that the white matter lesion in the cases with corticobasal degeneration/ progressive supranuclear palsy relates to glial, rather than axonal pathology is not only supported by past pathological studies; its lack of relationship to axonal loss was highlighted by the present finding that it was independent of disease severity (Table 2 ). This observation, nevertheless, emphasizes its diagnostic potential because the lesion was equally evident in even the most minimally impaired subject.
In summary, this study suggests that patients with putative tauopathies, corticobasal degeneration and progressive supranuclear palsy, have a distinct white matter diffusion tensor imaging profile that can be visualized at the level of the individual. This finding arose from studying patients with non-fluent primary progressive aphasia in whom corticobasal degeneration/progressive supranuclear palsy is one known pathological substrate. Further pathological confirmation of these findings will take some time but, in the interim, a next important step will be to determine whether the findings can be replicated in corticobasal degeneration/progressive supranuclear palsy presenting as a movement disorder, and in contrast to Parkinson's disease. To conclude, it is interesting to note that when unexpected profuse white matter tau pathology was first discovered in progressive supranuclear palsy by Zhukareva et al. (2006) , the authors speculated that it could have diagnostic implications if their discovery could be exploited by neuroimaging. The present findings suggest that diffusion tensor imaging may have now achieved this.
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